Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asymchem is a leading global contract development and manufacturing organization (CDMO) providing integrated solutions across the entire drug lifecycle. Headquartered in Tianjin, China, the company specializes in the development and commercial-scale manufacturing of small molecule APIs and intermediates, while rapidly expanding its capabilities into emerging modalities such as peptides, oligonucleotides, and biologics. Asymchem is globally recognized for its pioneering work in green chemistry and continuous flow manufacturing, which significantly improves production efficiency and environmental sustainability. The company supports a diverse range of clients, from big pharma to virtual biotech startups, through a network of R&D and manufacturing facilities in China, the United States, and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asymchem Life Science Tianjin.